March
29
neurolens Announces the nMD2
80% smaller than the first-generation nMD, and its diagnostic test is 35% faster Coppell,...
Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.